Localization of p43 placental isoferritin in human maternal-fetal tissue interface

American Journal of Obstetrics and Gynecology

Volumn 182, Issue 3, 2000, Pages 670-674

  Maymon, Ron ^a,b   Jauniaux, Eric ^b   Greenwold, Nathalie ^b   Moroz, Chaya ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Immunohistochemistry; Immunosuppressive activity; P43 isoferritin; Pregnancy

Indexed keywords

ISOFERRITIN; PLACENTA PROTEIN;

ARTICLE; FEMALE; FETOPLACENTAL UNIT; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; MACROPHAGE; MATERNAL SERUM; PREGNANCY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SYNCYTIOTROPHOBLAST;

EID: 0034030995     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1067/mob.2000.104145     Document Type: Article

References (25)

1. 1. Pollard JW. Lymphohematopoietic cytokines in the female reproductive tract. Curr Opin Immunol 1991;3:772-7.
2. 2. Robertson SA, Seamark RF, Guilbert LJ, Wegmann TG. The role of cytokines in gestation. Crit Rev Immunol 1994;14:239-92.
3. H2 phenomenon? Immunol Today 1993;14:353-6.
4. 4. Sirota L, Kupfer B, Moroz C. Placental isoferritin as a physiological down regulator of cellular immunoreactivity during pregnancy. Clin Exp Immunol 1989;77:257-62.
5. 5. Moroz C, Kupfer B, Twig S, Parhami-Seren B. Preparation and characterization of monoclonal antibodies specific to placental ferritin. Clin Chem 1985;114:111-8.
6. 6. Parhami-Seren B, Moroz C. A unique subunit of placental ferritin identified by the use of monoclonal antibodies. Ital J Clin Pathol 1986;1:17-23.
7. 7. Moroz C, Bessler H. Ferritin as a marker of malignancy. In: de Sousa M, Brock JH, editors. Iron in immunity, cancer and inflammation. New York: John Wiley and Sons; 1989. p. 283-99.
8. 8. Moroz C, Misrock S, Siegal FP. Isoferritins in HIV infection: relation to clinical stage CD8 lymphocyte binding and the pathogenesis of AIDS. AIDS 1989;3:11-6.
9. 9. Bentwich Z, Weisman Z, Moroz C, Bar-Yehuda S, Kalinkovich A. Immune dysregulation in Ethiopian immigrants in Israel: relevance to helminth infections? Clin Exp Immunol 1996;103: 239-43.
10. 10. Rosen HR, Ausch C, Reinerova M, Zaspin E, Renner K, Rosen AC, et al. Activated lymphocytes from breast cancer patients express the characteristics of type 2 helper cells: a possible role for breast cancer-associated p43. Cancer Lett 1998;127:129-34.
11. 11. Azumi N, Czernobilsky B. Immunohistochemistry. In: Kurman RJ, editor. Blaustein’s pathology of the female genital tract. 4th ed. New York: Springer-Verlag; 1994. p. 1131-52.
12. 12. Shi SR, Chaiwun B, Young L, Cote RJ, Taylor CR. Antigen retrieval technique utilizing citrate buffer or urea solution for immunohistochemical demonstration of androgen receptor in formalin-fixed paraffin sections. J Histochem Cytochem 1993; 41:1599-604.
13. 13. Chen H-L, Yang YP, Hu X-L, Yelavarthi KK, Fishback JL, Hunt JS. Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. Am J Pathol 1991;139:327-35.
14. 14. Hu X-L, Yang Y, Hunt JS. Differential distribution of interleukin-1α and interleukin-1β proteins in human placentas. J Reprod Immunol 1992;22:257-68.
15. 15. Panlesu L, King A, Loke YW, Cintorino M, Bellizzi E, Boraschi D. Immunohistochemical localization of IL-1 alpha and IL-1 beta in normal human placenta. Lymphokine Cytokine Res 1991;10:443-8.
16. 16. Jauniaux E, Gulbis B, Schandene L, Collette J, Hustin J. Distribution of interleukin-6 in maternal and embryonic tissues during the first trimester. Mol Hum Reprod 1996;2:239-43.
17. 17. De Moraes-Pinto MI, Vince GS, Flanagan BF, Hart CA, Johnson PM. Localization of IL-4 and IL-4 receptors in the human term placenta, decidua and amniochorionic membranes. Immunology 1997;90:87-94.
18. 18. Vince G, Shorter S, Starkey P, Humphreys J, Clover L, Wilkins T. Localization of tumour necrosis factor production in cells at the materno/fetal interface in human pregnancy. Clin Exp Immunol 1992;88:174-80.
19. 19. Rodesch F, Simon P, Donner C, Jauniaux E. Oxygen measurements in endometrial and trophoblastic tissues during early pregnancy. Obstet Gynecol 1992;80:283-5.
20. 20. Benyo DF, Miles TM, Conrad KP. Hypoxia stimulates cytokine production by villous explants from the human placenta. J Clin Endocrinol Metab 1997;82:1582-8.
21. 21. Maymon R, Moroz C. Placental isoferritin: a new biomarker from conception to delivery. Br J Obstet Gynaecol 1996;103:301-5.
22. 22. Maymon R, Jauniaux E, Rodeck C, Zatsepin L, Moroz C. Comparison of placental isoferritin levels in maternal serum, coelomic and amniotic fluids during first trimester human gestation. Hum Reprod 1998;13:1044-6.
23. 23. Castellucci M, Kaufmann P. Hofbauer cells. In: Benirschke K, Kaufmann P, editors. Pathology of the human placenta. 2nd ed. New York: Springer-Verlag; 1990.
24. 24. Maymon R, Bar J, Sherman D, Moroz C. Placental isoferritin levels in pregnant patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Am J Reprod Immunol 1998;40:95-101.
25. 25. Maymon R, Jauniaux E, Bar J, Moroz C. Maternal serum placental isoferritin levels in pregnant women with abnormal uterine artery Doppler velocimetry. Am J Perinatol 1998;15:607-12.